Doctors break down the difference between Wegovy’s GLP-1 injections and pills, plus how to decide which is right for you.

President Donald Trump went off script at a healthcare press conference to tell a wild story about an overweight billionaire ...

Semaglutide’s U.S. patents keep generics out until around 2031 or 2035, maintaining Novo Nordisk’s exclusivity and high ...

Weight loss drugs could quietly reshape airline economics, cutting fuel costs, boosting profits, and adding an unexpected ...

A food-oil supplement called Elcella can work like a weight-loss jab, it has been claimed - but experts say more evidence is ...

Semaglutide, sold under the brand names Wegovy and Ozempic, has helped Novo establish a foothold in the market for ...

The FAA provides guidance for operators through Advisory Circular (AC) 120-27F. Rather than weighing every individual, ...

Media mogul Oprah Winfrey is poised to change how we talk about the GLP-1 trend. It's part of the 'Oprah Effect' on wellness.

Novo Nordisk stock rose 4% after the U.K. approved a higher 7.2mg Wegovy dose and early prescription data showed strong ...

According to the Medicines and Healthcare products Regulatory Agency (MHRA), the new dose of 7.2mg is three times higher than ...

Novo Nordisk shares have surged on the back of its groundbreaking oral Wegovy approval, making it the first company to bring ...